» Articles » PMID: 23555253

The Enterovirus 71 A-particle Forms a Gateway to Allow Genome Release: a CryoEM Study of Picornavirus Uncoating

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2013 Apr 5
PMID 23555253
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Since its discovery in 1969, enterovirus 71 (EV71) has emerged as a serious worldwide health threat. This human pathogen of the picornavirus family causes hand, foot, and mouth disease, and also has the capacity to invade the central nervous system to cause severe disease and death. Upon binding to a host receptor on the cell surface, the virus begins a two-step uncoating process, first forming an expanded, altered "A-particle", which is primed for genome release. In a second step after endocytosis, an unknown trigger leads to RNA expulsion, generating an intact, empty capsid. Cryo-electron microscopy reconstructions of these two capsid states provide insight into the mechanics of genome release. The EV71 A-particle capsid interacts with the genome near the icosahedral two-fold axis of symmetry, which opens to the external environment via a channel ∼10 Å in diameter that is lined with patches of negatively charged residues. After the EV71 genome has been released, the two-fold channel shrinks, though the overall capsid dimensions are conserved. These structural characteristics identify the two-fold channel as the site where a gateway forms and regulates the process of genome release.

Citing Articles

Insight into the Life Cycle of Enterovirus-A71.

Liu Q, Long J Viruses. 2025; 17(2).

PMID: 40006936 PMC: 11861800. DOI: 10.3390/v17020181.


Virus-Receptor Interactions and Receptor-Mediated Virus Entry into Host Cells.

Casasnovas J Subcell Biochem. 2024; 105:533-566.

PMID: 39738957 DOI: 10.1007/978-3-031-65187-8_15.


Endosome rupture enables enteroviruses from the family Picornaviridae to infect cells.

Ishemgulova A, Mukhamedova L, Trebichalska Z, Rajecka V, Payne P, Smerdova L Commun Biol. 2024; 7(1):1465.

PMID: 39511383 PMC: 11543853. DOI: 10.1038/s42003-024-07147-9.


Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2.

Zhu R, Wu Y, Huang Y, Jiang Y, Jiang Y, Zhang D Nat Microbiol. 2024; 9(11):2939-2953.

PMID: 39424982 DOI: 10.1038/s41564-024-01822-7.


Tanomastat exerts multi-targeted inhibitory effects on viral capsid dissociation and RNA replication in human enteroviruses.

Lim T, Jaladanki C, Wong Y, Yogarajah T, Fan H, Chu J EBioMedicine. 2024; 107:105277.

PMID: 39226680 PMC: 11419895. DOI: 10.1016/j.ebiom.2024.105277.


References
1.
Jacobson M, Baltimore D . Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J Mol Biol. 1968; 33(2):369-78. DOI: 10.1016/0022-2836(68)90195-2. View

2.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

3.
Oppermann H, Koch G . Kinetics of poliovirus replication in HeLa cells infected by isolated RNA. Biochem Biophys Res Commun. 1973; 52(2):635-40. DOI: 10.1016/0006-291x(73)90760-2. View

4.
Yang B, Chuang H, Yang K . Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009; 6:141. PMC: 2751754. DOI: 10.1186/1743-422X-6-141. View

5.
Chan L, Parashar U, Lye M, Ong F, Zaki S, Alexander J . Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000; 31(3):678-83. DOI: 10.1086/314032. View